Article Details
Retrieved on: 2023-01-04 07:50:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Credit Suisse Group reiterated a neutral rating and issued a £110 ($132.53) price target on shares of AstraZeneca in a research note on Friday, ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here